在被诊断为双极性疾病的患者中,每月一次对阿里皮普拉的暴露反应分析
Xiaofeng Wang1, Luann Phillips2, Matthew Harlin3
1Pharmacometrics, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA.
Clinical pharmacology in drug development
|August 22, 2025
概括
每月一次的阿里皮普拉维护疗法可降低双相I型精神障碍的复发风险. 95 ng/ mL的度与情绪事件复发的显著减少有关.
科学领域:
- 药理学
- 精神病学
- 临床药房
背景情况:
- 每月一次的阿里皮普拉 (AOM) 适用于双相I型精神障碍 (BP- I) 的维持单疗法.
- 了解药物暴露与治疗结果之间的关系对于优化治疗至关重要.
研究的目的:
- 在BP- I患者中验证AOM的群体药动力学模型.
- 开发一个暴露-反应模型,以评估阿里皮普拉暴露对BP- I情绪事件复发的影响.
主要方法:
- 使用BP- I患者数据验证了一个群体药动力学模型.
- 为暴露-反应模型生成的阿里皮普拉暴露数据.
- 使用连续和分类模型来分析复发风险.
主要成果:
- 较高的阿里皮普拉暴露与情绪事件复发的风险降低有关.
- 每增加1ng/ mL的血,复发风险降低了0. 34%.
- 血度为95 ng/ mL显著预测复发时间,降低了36%的风险.
结论:
- 血阿里皮普拉的度是AOM的BP- I患者复发的关键预测因素.
- 用AOM进行维持治疗对于预防情绪发作很重要.
- 对于BP-I来说,95 ng/mL的值是重要的,比精神分裂症更小的效果.
相关概念视频
Bipolar Disorder
142
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
142
Mania and Antimanic Drugs: Overview
319
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
319
Psychosis: Goals of Pharmacotherapy
209
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
209
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Antidepressant Drugs: MAOIs and Other Agents
344
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
344
Psychosis and Antipsychotic Drugs: Overview
454
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
454


